Qube Research & Technologies (QRT)
SRNE

Qube Research & Technologies (QRT)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,034,729
Closed -$917K – 3187
2022
Q4 		$917K Buy
1,034,729
+710,440
+219% +$942K 0.01% 1256
2022
Q3 		$509K Buy
324,289
+276,396
+577% +$627K ﹤0.01% 1459
2022
Q2 		$96K Sell
47,893
-251,614
-84% -$435K ﹤0.01% 1961
2022
Q1 		$698K Buy
299,507
+274,669
+1,106% +$857K 0.01% 1366
2021
Q4 		$115K Buy
+24,838
New +$154K ﹤0.01% 2111

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return